Two BlueCross plans select TriZetto?s claims software

TriMed Staff | | Health Imaging | Practice Management
Blue Cross and Blue Shield of Kansas City (BCBSKC) and Blue Cross and Blue Shield of Rhode Island (BCBSRI) have chosen the TriZetto Group’s real-time patient liability and point-of-service claims adjudication software, Provider POS Direct.

The Provider POS Direct application will be hosted for BCBSRI in a TriZetto data center. The Provider POS Direct software can be integrated with provider information systems and core payor administrative systems. The software is built on service-oriented architecture (SOA), with internet browser capability, web services for HIPAA compliance and ease of interoperability with legacy applications, according to the Newport Beach, Calif.-based TriZetto.

TriMed Staff

Related Content

COVID restrictions left many rad tech students 'very unprepared' for workforce
Clinicians want AI to show its work
Multidose contrast injectors could increase waste in some radiology departments
Imaging leaders share 7 key considerations for remote scanning programs
Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.